Alkermes (ALKS) Tops Q1 EPS by 5c
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $49.06 --0%
Financial Fact:
Product sales, net: 5.3M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Product sales, net: 5.3M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q1 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $223.1 million versus the consensus estimate of $216.99 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
- Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
